mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection.

Front Immunol · 2023 · PMC10338867 · PMID 37457694

Europe PMC DOI

hedged sentence

0.0750

closest p · 1.5× alpha

0.0750

boldest claim

The sentences

did not reach statistical significancep=0.075so close (0.05 < p ≤ 0.1)

It is noteworthy to note that although the memory B cell response tended to be higher in recovered patients with severe disease compared to those with moderate/asymptomatic disease, this did not reach statistical significance (p=0.075, N=9).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.